Xiaoli Liu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Targeting the PARP10-BCAT2 axis disrupts branched-chain amino-acid metabolism to suppress bone metastasis in lung cancer.

Targeting the PARP10-BCAT2 axis disrupts branched-chain amino-acid metabolism to suppress bone metastasis in lung cancer.

Journal: Cell death & disease

Published: December 29, 2025

U2AF2-regulated alternative splicing of UPP1 promotes NSCLC progression by enhancing glycolysis.

U2AF2-regulated alternative splicing of UPP1 promotes NSCLC progression by enhancing glycolysis.

Journal: Cell communication and signaling : CCS

Published: December 03, 2025

Establishment and comprehensive characterization of a subline with highly bone-metastatic propensity derived from the lung adenocarcinoma A549 cell line.

Establishment and comprehensive characterization of a subline with highly bone-metastatic propensity derived from the lung adenocarcinoma A549 cell line.

Journal: Journal of bone oncology

Published: July 16, 2025

C/EBP-α Promotes Mitochondrial Fission and Inhibits the Activation of Hepatic Stellate Cells via YAP-Drp1 Pathway.

C/EBP-α Promotes Mitochondrial Fission and Inhibits the Activation of Hepatic Stellate Cells via YAP-Drp1 Pathway.

Journal: Cell biology international

Published: February 05, 2025

RBIS regulates ribosome biogenesis to affect progression in lung adenocarcinoma.

RBIS regulates ribosome biogenesis to affect progression in lung adenocarcinoma.

Journal: Journal of translational medicine

Published: March 28, 2024

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway.

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway.

Journal: Journal of thoracic disease

Published: January 02, 2024

CDK12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells.

CDK12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells.

Journal: Molecular and cellular probes

Published: March 23, 2023

Metformin induces mitochondrial fission and reduces energy metabolism by targeting respiratory chain complex I in hepatic stellate cells to reverse liver fibrosis.

Metformin induces mitochondrial fission and reduces energy metabolism by targeting respiratory chain complex I in hepatic stellate cells to reverse liver fibrosis.

Journal: The international journal of biochemistry & cell biology

Published: September 01, 2022

Targeted lipidomics analysis of lysine 179 acetylation of ACSF2 in rat hepatic stellate cells.

Targeted lipidomics analysis of lysine 179 acetylation of ACSF2 in rat hepatic stellate cells.

Journal: Prostaglandins & other lipid mediators

Published: April 30, 2022

Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin.

Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin.

Journal: International immunopharmacology

Published: December 19, 2021

DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.

DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.

Journal: Experimental cell research

Published: June 08, 2021

LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.

LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.

Journal: Translational cancer research

Published: May 23, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026